TrademarkDir
MENBESRY
LIVE

Serial Number

97251126

Owner

GlaxoSmithKline Biologicals SA

Attorney

Christopher M. Hanes

Filing Date

Feb 2, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

MENBESRY Trademark

Serial Number: 97251126 • Registration: 7416906

MENBESRY is a trademark filed by GlaxoSmithKline Biologicals SA on February 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

GlaxoSmithKline Biologicals SA (140 trademarks)

Rue de l'Institut 89
B-1330 Rixensart , BE

Entity Type: 99

Trademark Details

Filing Date

February 2, 2022

Registration Date

June 18, 2024

Published for Opposition

April 2, 2024

Goods & Services

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 18, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 18, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 2, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2024 CRFA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 7, 2024 CHAN
ASSIGNED TO LIE
Feb 6, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 15, 2023 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 30, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 30, 2023 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 30, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 30, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
May 30, 2023 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 22, 2023 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 16, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 16, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 16, 2022 CNSL
ASSIGNED TO EXAMINER
Nov 15, 2022 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 3, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Aug 3, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 3, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 3, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 8, 2022 NWOS
NEW APPLICATION ENTERED
Feb 5, 2022 NWAP

Related Trademarks

More from this Owner

AS04

AS04

KYDVARIX

KYDVARIX

VAXBEMVO

VAXBEMVO

EASYVAX

EASYVAX

TRUSESFLU

TRUSESFLU

TRUSESFLU

TRUSESFLU